Search clinical trials for: Cabozantinib
Total 274 results
-
University of Michigan Rogel Cancer CenterExelixisTerminatedProstate Cancer MetastaticUnited States
-
Edwin Posadas, MDCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterExelixisCompletedRelapsed or Refractory Multiple MyelomaUnited States
-
Massachusetts General HospitalExelixisCompletedRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
Massachusetts General HospitalCompletedMultiple MyelomaUnited States
-
Massachusetts General HospitalExelixisCompletedBile Duct Cancer | Intrahepatic Cholangiocarcinoma | Cholangiocarcinoma of the Extrahepatic Bile DuctUnited States
-
Dana-Farber Cancer InstituteCompleted
-
Massachusetts General HospitalCompletedProstate AdenocarcinomaUnited States
-
Joseph RoscoeNational Cancer Institute (NCI)Completed
-
ExelixisCompletedCancer | NSCLC | Solid TumorsJapan
-
Inje UniversityCompletedFeverKorea, Republic of
-
ExelixisTerminatedProstatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
ExelixisCompletedGlioblastoma | Gliosarcoma | Giant Cell GlioblastomaUnited States
-
ExelixisCompletedHealthy | Hepatic ImpairmentUnited States
-
ExelixisCompletedHealthy | Renal ImpairmentUnited States
-
ExelixisCompletedAstrocytic TumorsUnited States, Canada
-
ExelixisCompletedCarcinoma, Non-Small-Cell LungUnited States
-
ExelixisCompletedRenal Cell Carcinoma | Papillary Thyroid Cancer | Follicular Thyroid Cancer | Huerthle Cell Thyroid CancerUnited States
-
Istituto Scientifico H. San RaffaeleUnknown
-
ExelixisCompletedLymphoma | Cancer | Thyroid CarcinomaUnited States
-
ExelixisApproved for marketing
-
University of SalernoUnknownDifferentiated Thyroid CancerItaly